A Systematic Review about the Efficacy and Safety of Tripterygium wilfordii Hook.f. Preparations Used for the Management of Rheumatoid Arthritis

Abstract EN

Tripterygium wilfordii Hook.f.

(TWHF) is a traditional Chinese herb long used for rheumatoid arthritis (RA) treatment, in modern times, often in the form of various Tripterygium wilfordii Hook.f.

preparations (TWPs).

This systematic review and meta-analysis focuses on analyzing the clinical efficacy and safety of TWPs in the treatment of RA.

Databases were searched to collect the randomized controlled trials (RCTs) on TWPs treating RA published on or before April 10, 2017.

Data from 11 studies were included in this meta-analysis.

Compared with the control group, TWPs can increase effectiveness, while decreasing erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), C-reactive protein (CRP), and risk of adverse events.

TWPs treatment was also more effective than treatment by conventional western medicine (CWM) and Chinese patent medicine or placebo (COP).

TWPs significantly decreased the risk of adverse events compared with the CWM group, but not compared with the COP group.

Current evidence shows that TWPs are more effective than other western or Chinese medicines we included in this meta-analysis for RA treatment with relatively lower toxicity.